calciumacetat-nefro 700 mg apvalkotās tabletes
medice arzneimittel putter gmbh & co.kg, germany - kalcija acetāts - apvalkotās tabletes - 700 mg
nefrocarnit 1 g/3,3 ml šķīdums iekšķīgai lietošanai
medice arzneimittel putter gmbh & co.kg, germany - levokarnitīns - Šķīdums iekšķīgai lietošanai - 1 g/3,3 ml
nefrocarnit 1 g/5 ml šķīdums injekcijām
medice arzneimittel putter gmbh & co.kg, germany - levokarnitīns - Šķīdums injekcijām - 1 g/5 ml
thiafeline
le vet beheer b.v., nīderlande - thiamazol - tabletes - 2.5 mg - kaķi
darzalex
janssen-cilag international n.v. - daratumumabs - multiple mieloma - monoclonal antibodies and antibody drug conjugates, antineoplastic agents - multiple myelomadarzalex is indicated: in combination with lenalidomide and dexamethasone or with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. kopā ar bortezomib, talidomīds un deksametazona ārstēšanai pieaugušiem pacientiem, kuriem nesen diagnosticēta multiplā mieloma, kuri ir tiesīgi saņemt autologās cilmes šūnu transplantācijas. kopā ar lenalidomide un deksametazona, vai bortezomib un deksametazona, ārstēšanai pieaugušiem pacientiem ar multiplā mieloma, kuri ir saņēmuši vismaz vienu pirms terapijas. in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received one prior therapy containing a proteasome inhibitor and lenalidomide and were lenalidomide refractory, or who have received at least two prior therapies that included lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or after the last therapy (see section 5. kā monotherapy ārstēšanai pieaugušiem pacientiem ar relapsed un ugunsizturīgo multiplā mieloma, kuru pirms terapijas iekļauts proteasome inhibitoru un imūnmodulējošu līdzekli un kas ir pierādījuši slimības progresēšanu pēdējā terapija. al amyloidosisdarzalex is indicated in combination with cyclophosphamide, bortezomib and dexamethasone for the treatment of adult patients with newly diagnosed systemic light chain (al) amyloidosis.
herbalifeline® max (2017.) kapsula
catalent pharma solutions s.p.a - kapsula
lifelines triphala (2023.) kapsula
kapsula
lifelines shatavari (2023.) kapsula
kapsula
lifelines guduchi (2023.) kapsula
kapsula
lifelines curcumin max (2023.) kapsula
kapsula